Search research articles
Contact Us
Filters
Showing results (151-160 of 217) with videos related to
Page
of 22
Sort By:
Cancer Research and Treatment
|
July 12, 2019
Clinical Outcomes of Second-Line Chemotherapy after Progression on Nab-Paclitaxel Plus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
Kyoungmin Lee, Kyunghye Bang, Changhoon Yoo, et al.
Human Pathology
|
September 28, 2018
High-grade precursor lesions can be used as surrogate markers to identify the epicenter of periampullary carcinomas
Byung-Kwan Jeong, You Na Sung, Sung Joo Kim, et al.
Hepatology (Baltimore, Md.)
|
April 18, 2023
Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial
Hyehyun Jeong, Kyu-Pyo Kim, Jae Ho Jeong, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 5, 2024
Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancreatic adenocarcinoma (NASOX): A multicenter phase I/IIa study
Hyehyun Jeong, Bum Jun Kim, Choong-Kun Lee, et al.
Cancer Research and Treatment
|
January 16, 2018
Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer
Changhoon Yoo, Boram Han, Hyeong Su Kim, et al.
Oncotarget
|
April 27, 2017
Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinoma
Changhoon Yoo, Jihoon Kang, Deokhoon Kim, et al.
Oncology
|
August 21, 2014
Single-nucleotide polymorphisms in the vascular endothelial growth factor pathway and outcomes of patients treated with first-line cytotoxic chemotherapy combined with bevacizumab for advanced colorectal cancer
Byeong Seok Sohn, Seong Joon Park, Jeong Eun Kim, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 31, 2016
Phase 1 Study of Preoperative Chemoradiation Therapy With Temozolomide and Capecitabine in Patients With Locally Advanced Rectal Cancer
Jae Ho Jeong, Yong Sang Hong, Yangsoon Park, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 22, 2018
Total Mesorectal Excision Versus Local Excision After Preoperative Chemoradiotherapy in Rectal Cancer With Lymph Node Metastasis: A Propensity Score-Matched Analysis
Young Seob Shin, Jin-Hong Park, Sang Min Yoon, et al.
Clinical Therapeutics
|
November 19, 2008
Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study
Kyoung Soo Lim, Jung-Ryul Kim, Yun-Jung Choi, et al.
Page
of 22
Search research articles
Search
Showing results (151-160 of 217) with videos related to
Sort By:
Page
of 22
Cancer Research and Treatment
|
July 12, 2019
Clinical Outcomes of Second-Line Chemotherapy after Progression on Nab-Paclitaxel Plus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma
Kyoungmin Lee, Kyunghye Bang, Changhoon Yoo, et al.
Human Pathology
|
September 28, 2018
High-grade precursor lesions can be used as surrogate markers to identify the epicenter of periampullary carcinomas
Byung-Kwan Jeong, You Na Sung, Sung Joo Kim, et al.
Hepatology (Baltimore, Md.)
|
April 18, 2023
Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial
Hyehyun Jeong, Kyu-Pyo Kim, Jae Ho Jeong, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 5, 2024
Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancreatic adenocarcinoma (NASOX): A multicenter phase I/IIa study
Hyehyun Jeong, Bum Jun Kim, Choong-Kun Lee, et al.
Cancer Research and Treatment
|
January 16, 2018
Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer
Changhoon Yoo, Boram Han, Hyeong Su Kim, et al.
Oncotarget
|
April 27, 2017
Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinoma
Changhoon Yoo, Jihoon Kang, Deokhoon Kim, et al.
Oncology
|
August 21, 2014
Single-nucleotide polymorphisms in the vascular endothelial growth factor pathway and outcomes of patients treated with first-line cytotoxic chemotherapy combined with bevacizumab for advanced colorectal cancer
Byeong Seok Sohn, Seong Joon Park, Jeong Eun Kim, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 31, 2016
Phase 1 Study of Preoperative Chemoradiation Therapy With Temozolomide and Capecitabine in Patients With Locally Advanced Rectal Cancer
Jae Ho Jeong, Yong Sang Hong, Yangsoon Park, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 22, 2018
Total Mesorectal Excision Versus Local Excision After Preoperative Chemoradiotherapy in Rectal Cancer With Lymph Node Metastasis: A Propensity Score-Matched Analysis
Young Seob Shin, Jin-Hong Park, Sang Min Yoon, et al.
Clinical Therapeutics
|
November 19, 2008
Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study
Kyoung Soo Lim, Jung-Ryul Kim, Yun-Jung Choi, et al.
Page
of 22